RecruitingNot applicableNCT06374238
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Sponsor: University of Pittsburgh
Atlanta, GA · +13 more sites
Sickle Cell Disease clinical trials in Atlanta, GA
22 recruiting sickle cell disease studies with a site in Atlanta, GA.
RecruitingPhase 2NCT06699849
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Sponsor: CSL Behring
Atlanta, GA · +19 more sites
RecruitingPhase 1NCT07187973
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Sponsor: Disc Medicine, Inc
Atlanta, GA · Augusta, GA · +9 more sites
RecruitingPhase 3NCT06609226
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sponsor: Novo Nordisk A/S
Atlanta, GA · Augusta, GA · +36 more sites
RecruitingPhase 3NCT06612268
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sponsor: Novo Nordisk A/S
Atlanta, GA · +49 more sites
RecruitingNot applicableNCT07562451
Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
Sponsor: Emory University
Atlanta, GA
RecruitingPhase 2 / Phase 3NCT05431088
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sponsor: Pfizer
Atlanta, GA · Dunwoody, GA · Riverdale, GA · +43 more sites
RecruitingPhase 1 / Phase 2NCT06481306
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Sponsor: Bristol-Myers Squibb
Atlanta, GA · +18 more sites
RecruitingPhase not listedNCT04398628
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Sponsor: American Thrombosis and Hemostasis Network
Atlanta, GA · Savannah, GA · +73 more sites
RecruitingPhase 2NCT07224360
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Sponsor: CSL Behring
Atlanta, GA · +8 more sites
RecruitingPhase 1 / Phase 2NCT02447874
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
Sponsor: Emory University
Atlanta, GA
RecruitingPhase not listedNCT06941389
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Sponsor: University of Rochester
Atlanta, GA · +30 more sites
RecruitingPhase 1 / Phase 2NCT07252050
Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Sponsor: Arkansas Children's Hospital Research Institute
Atlanta, GA · +3 more sites
RecruitingPhase 4NCT06665997
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Sponsor: University of Pennsylvania
Atlanta, GA · +1 more sites
RecruitingNot applicableNCT06290401
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
Sponsor: Children's Hospital Medical Center, Cincinnati
Atlanta, GA · +3 more sites
RecruitingPhase 3NCT07247188
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
Sponsor: Sanofi
Atlanta, GA · +3 more sites
RecruitingPhase 4NCT06979492
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
Sponsor: Emory University
Atlanta, GA
RecruitingPhase not listedNCT07373639
A Long-term Follow-up Study in Patients Who Received BEAM-101
Sponsor: Beam Therapeutics Inc.
Atlanta, GA · +16 more sites
RecruitingNot applicableNCT07090668
Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease
Sponsor: Emory University
Atlanta, GA
RecruitingNot applicableNCT06691867
Integrative Training Program for Pediatric Sickle Cell Pain
Sponsor: Emory University
Atlanta, GA · +2 more sites
Not yet recruitingNot applicableNCT06743113
Hypoxic Red Blood Cells in Sickle Cell Anemia
Sponsor: Hemanext
Atlanta, GA · +4 more sites
Not yet recruitingPhase 3NCT06989567
A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis
Sponsor: Asklepion Pharmaceuticals, LLC
Atlanta, GA · +5 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.